Metabolite profile of a mouse model of Charcot-Marie-Tooth type 2D neuropathy: Implications for disease mechanisms and interventions

Biology Open

Volumn 5, Issue 7, 2016, Pages 908-920

  Bais, Preeti ^a   Beebe, Kirk ^b   Morelli, Kathryn H ^a,c   Currie, Meagan E ^a   Norberg, Sara N ^a   Evsikov, Alexei V ^a,d   Miers, Kathy E ^a   Seburn, Kevin L ^a   Guergueltcheva, Velina ^e,h   Kremensky, Ivo ^f   Jordanova, Albena ^e,g   Bult, Carol J ^a   Burgess, Robert W ^a,c  

^a JACKSON LABORATORY   (United States)

^b METABOLON INC   (United States)

^c UNIVERSITY OF MAINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^f University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

^g UNIVERSITY OF ANTWERP   (Belgium)

^h UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Mass spectrometry; Metabolomics; Peripheral neuropathy; Sciatic nerve; Spinal cord; TRNA synthetase

Indexed keywords

ASCORBIC ACID; CARNITINE; CARNITINE DERIVATIVE; GLYCINE; LEVACECARNINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXPERIMENTAL MODEL; HEREDITARY MOTOR SENSORY NEUROPATHY; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; METABOLITE; MOTOR PERFORMANCE; MOUSE; NEUROMUSCULAR DISEASE; NONHUMAN; PHENOTYPE; SPINAL CORD;

EID: 84985986991     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.019273     Document Type: Article

References (66)

1. Achilli, F., Bros-Facer, V., Williams, H. P., Banks, G. T., AlQatari, M., Chia, R., Tucci, V., Groves, M., Nickols, C. D., Seburn, K. L. et al. (2009). An ENUinduced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis. Model. Mech. 2, 359-373.
2. Adebola, A. A., Di Castri, T., He, C.-Z., Salvatierra, L. A., Zhao, J., Brown, K., Lin, C.-S., Worman, H. J. and Liem, R. K. H. (2015). Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype. Hum. Mol. Genet. 24, 2163-2174.
3. Antonellis, A. and Green, E. D. (2008). The role of aminoacyl-tRNA synthetases in genetic diseases. Annu. Rev. Genomics Hum. Genet. 9, 87-107.
4. Antonellis, A., Ellsworth, R. E., Sambuughin, N., Puls, I., Abel, A., Lee-Lin, S.-Q., Jordanova, A., Kremensky, I., Christodoulou, K., Middleton, L. T. et al. (2003). Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72, 1293-1299.
5. Bogdanik, L. P. and Burgess, R. W. (2011). A valid mouse model of AGRINassociated congenital myasthenic syndrome. Hum. Mol. Genet. 20, 4617-4633.
6. Burgess, R. W., Cox, G. A. and Seburn, K. L. (2010). Neuromuscular disease models and analysis. Methods Mol. Biol. 602, 347-393.
7. Burns, J., Ouvrier, R. A., Yiu, E. M., Joseph, P. D., Kornberg, A. J., Fahey, M. C. and Ryan, M. M. (2009). Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 8, 537-544.
8. Callander, N., Markovina, S., Eickhoff, J., Hutson, P., Campbell, T., Hematti, P., Go, R., Hegeman, R., Longo, W., Williams, E. et al. (2014). Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother. Pharmacol. 74, 875-882.
9. Casey, J. P., McGettigan, P., Lynam-Lennon, N., McDermott, M., Regan, R., Conroy, J., Bourke, B., O'Sullivan, J., Crushell, E., Lynch, S. et al. (2012). Identification of a mutation in LARS as a novel cause of infantile hepatopathy. Mol. Genet. Metab. 106, 351-358.
10. Cassol, E., Misra, V., Holman, A., Kamat, A., Morgello, S. and Gabuzda, D. (2013). Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infect. Dis. 13, 203.
11. Chan, K. M., Gordon, T., Zochodne, D. W. and Power, H. A. (2014). Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets. Exp. Neurol. 261, 826-835.
12. Cherdyntseva, N. V., Ivanova, A. A., Ivanov, V. V., Cherdyntsev, E., Nair, C. K. and Kagiya, T. V. (2013). Ascorbic acid glucoside reduces neurotoxicity and glutathione depletion in mouse brain induced by nitrotriazole radiosensitazer. J. Cancer Res. Ther. 9, 364-369.
13. Chiechio, S., Copani, A., Gereau, R. W, IV and Nicoletti, F. (2007). Acetyl-Lcarnitine in neuropathic pain: experimental data. CNS Drugs 21 Suppl. 1, 31-38; discussion 45-46.
14. Christodoulou, K., Kyriakides, T., Hristova, A. H., Georgiou, D.-M., Kalaydjieva, L., Yshpekova, B., Ivanova, T., Weber, J. L. and Middleton, L. T. (1995). Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum. Mol. Genet. 4, 1629-1632.
15. Dawkins, J. L., Hulme, D. J., Brahmbhatt, S. B., Auer-Grumbach, M. and Nicholson, G. A. (2001). Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 27, 309-312.
16. DeHaven, C. D., Evans, A. M., Dai, H. and Lawton, K. A. (2010). Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J. Cheminform 2, 9.
17. Dieterle, F., Ross, A., Schlotterbeck, G. and Senn, H. (2006). Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 78, 4281-4290.
18. Eichler, F. S., Hornemann, T., McCampbell, A., Kuljis, D., Penno, A., Vardeh, D., Tamrazian, E., Garofalo, K., Lee, H.-J., Kini, L. et al. (2009). Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J. Neurosci. 29, 14646-14651.
19. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M. and Milgram, E. (2009). Integrated, nontargeted ultrahigh performance liquid chromatography/ electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem. 81, 6656-6667.
20. Fritz, I. B., Davis, D. G., Holtrop, R. H. and Dundee, H. (1958). Fatty acid oxidation by skeletal muscle during rest and activity. Am. J. Physiol. 194, 379-386.
21. Furusawa, H., Sato, Y., Tanaka, Y., Inai, Y., Amano, A., Iwama, M., Kondo, Y., Handa, S., Murata, A., Nishikimi, M. et al. (2008). Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice. Biol. Pharm. Bull. 31, 1673-1679.
22. Griffin, L. B., Sakaguchi, R., McGuigan, D., Gonzalez, M. A., Searby, C., Zuchner, S., Hou, Y. M. and Antonellis, A. (2014). Impaired function is a common feature of neuropathy-associated Glycyl-tRNA synthetase mutations. Hum. Mutat.. 35, 1363-1371.
23. Hagen, T. M., Liu, J., Lykkesfeldt, J., Wehr, C. M., Ingersoll, R. T., Vinarsky, V., Bartholomew, J. C. and Ames, B. N. (2002). Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. USA 99, 1870-1875.
24. Hart, A. M., Wiberg, M., Youle, M. and Terenghi, G. (2002). Systemic acetyl-Lcarnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp. Brain Res. 145, 182-189.
25. He, W., Bai, G., Zhou, H., Wei, N., White, N. M., Lauer, J., Liu, H., Shi, Y., Dumitru, C. D., Lettieri, K. et al. (2015). CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature 526, 710-714.
26. Huzé, C., Bauché, S., Richard, P., Chevessier, F., Goillot, E., Gaudon, K., Ben Ammar, A., Chaboud, A., Grosjean, I., Lecuyer, H.-A. et al. (2009). Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am. J. Hum. Genet. 85, 155-167.
27. Jordanova, A., Irobi, J., Thomas, F. P., Van Dijck, P., Meerschaert, K., Dewil, M., Dierick, I., Jacobs, A., De Vriendt, E., Guergueltcheva, V. et al. (2006). Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat. Genet. 38, 197-202.
28. Karsidag, S., Akcal, A., Sahin, S., Karsidag, S., Kabukcuoglu, F. and Ugurlu, K. (2012). Neurophysiological and morphological responses to treatment with acetyl-L-carnitine in a sciatic nerve injury model: preliminary data. J. Hand Surg. Eur. Vol 37, 529-536.
29. Kuhn, M. (2008). Building predictive models in r using the caret package. J. Stat. Softw. 28, 1-26.
30. Latour, P., Thauvin-Robinet, C., Baudelet-Meày, C., Soichot, P., Cusin, V., Faivre, L., Locatelli, M.-C., Mayençon, M., Sarcey, A., Broussolle, E. et al. (2010). A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic alanyl-tRNA synthetase is mutated in dominant axonal charcotmarie-tooth disease. Am. J. Hum. Genet. 86, 77-82.
31. Li, Y., Shi, C.-X., Mossman, K. L., Rosenfeld, J., Boo, Y. C. and Schellhorn, H. E. (2008). Restoration of vitamin C synthesis in transgenic Gulo-/- mice by helperdependent adenovirus-based expression of gulonolactone oxidase. Hum. Gene Ther. 19, 1349-1358.
32. Liu, J., Head, E., Gharib, A. M., Yuan, W., Ingersoll, R. T., Hagen, T. M., Cotman, C. W. and Ames, B. N. (2002a). Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-Lcarnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. USA 99, 2356-2361.
33. Liu, J., Killilea, D. W. and Ames, B. N. (2002b). Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. USA 99, 1876-1881.
34. Liu, J., Head, E., Kuratsune, H., Cotman, C. W. and Ames, B. N. (2004). Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann. N Y Acad. Sci. 1033, 117-131.
35. Mao, Y.-F., Liu, X.-R., Liao, X.-Z., Lv, Y.-H., Xu, H., Deng, X.-M., Yan, S.-K., Xiong, Y.-C. and Zhang, W.-D. (2009). Blood serum profiling of the rat spinal nerve ligation model using ultra-performance liquid chromatography-quadrupole timeof-flight mass spectrometry. Eur. J. Pharmacol. 615, 61-65.
36. Maselli, R. A., Fernandez, J. M., Arredondo, J., Navarro, C., Ngo, M., Beeson, D., Cagney, O., Williams, D. C., Wollmann, R. L., Yarov-Yarovoy, V. et al. (2011). LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin. Hum. Genet.. 131, 1123-1135.
37. McLaughlin, H. M., Sakaguchi, R., Liu, C., Igarashi, T., Pehlivan, D., Chu, K., Iyer, R., Cruz, P., Cherukuri, P. F., Hansen, N. F. et al. (2010). Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am. J. Hum. Genet. 87, 560-566.
38. Micallef, J., Attarian, S., Dubourg, O., Gonnaud, P.-M., Hogrel, J.-Y., Stojkovic, T., Bernard, R., Jouve, E., Pitel, S., Vacherot, F. et al. (2009). Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 8, 1103-1110.
39. Motley, W. W., Talbot, K. and Fischbeck, K. H. (2010). GARS axonopathy: not every neuron's cup of tRNA. Trends Neurosci. 33, 59-66.
40. Motley, W. W., Seburn, K. L., Nawaz, M. H., Miers, K. E., Cheng, J., Antonellis, A., Green, E. D., Talbot, K., Yang, X.-L., Fischbeck, K. H. et al. (2011). Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet. 7, e1002399.
41. Niehues, S., Bussmann, J., Steffes, G., Erdmann, I., Köhrer, C., Sun, L., Wagner, M., Scha?fer, K., Wang, G., Koerdt, S. N. et al. (2015). Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases. Nat. Commun. 6, 7520.
42. Pareyson, D., Schenone, A., Fabrizi, G. M., Santoro, L., Padua, L., Quattrone, A., Vita, G., Gemignani, F., Visioli, F. and Solari, A. (2006). A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol. Res. 54, 436-441.
43. Pareyson, D., Reilly, M. M., Schenone, A., Fabrizi, G. M., Cavallaro, T., Santoro, L., Vita, G., Quattrone, A., Padua, L., Gemignani, F. et al. (2011). Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol. 10, 320-328.
44. Park, S. G., Schimmel, P. and Kim, S. (2008). Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl. Acad. Sci. USA 105, 11043-11049.
45. Passage, E., Norreel, J. C., Noack-Fraissignes, P., Sanguedolce, V., Pizant, J., Thirion, X., Robaglia-Schlupp, A., Pellissier, J. F. and Fonteœ, M. (2004). Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10, 396-401.
46. Penno, A., Reilly, M. M., Houlden, H., Laura, M., Rentsch, K., Niederkofler, V., Stoeckli, E. T., Nicholson, G., Eichler, F., Brown, R. H., Jr. et al. (2010). Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J. Biol. Chem. 285, 11178-11187.
47. Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B. and Yan, H. (2011). Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc. Natl. Acad. Sci. USA 108, 3270-3275.
48. Rotthier, A., Auer-Grumbach, M., Janssens, K., Baets, J., Penno, A., Almeida-Souza, L., Van Hoof, K., Jacobs, A., De Vriendt, E., Schlotter-Weigel, B. et al. (2010). Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am. J. Hum. Genet. 87, 513-522.
49. Rozen, S., Cudkowicz, M. E., Bogdanov, M., Matson, W. R., Kristal, B. S., Beecher, C., Harrison, S., Vouros, P., Flarakos, J., Vigneau-Callahan, K. et al. (2005). Metabolomic analysis and signatures in motor neuron disease. Metabolomics 1, 101-108.
50. Scheper, G. C., van der Klok, T., van Andel, R. J., van Berkel, C. G. M., Sissler, M., Smet, J., Muravina, T. I., Serkov, S. V., Uziel, G., Bugiani, M. et al. (2007). Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat. Genet. 39, 534-539.
51. Schimmel, P. (2008). Development of tRNA synthetases and connection to genetic code and disease. Protein Sci. 17, 1643-1652.
52. Seburn, K. L., Nangle, L. A., Cox, G. A., Schimmel, P. and Burgess, R. W. (2006). An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51, 715-726.
53. Shlomai, A., Halfon, P., Goldiner, I., Zelber-Sagi, S., Halpern, Z., Oren, R. and Bruck, R. (2013). Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C. J. Viral Hepat 20, 95-102.
54. Sing, T., Sander, O., Beerenwinkel, N. and Lengauer, T. (2005). ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940-3941.
55. Sivakumar, K., Kyriakides, T., Puls, I., Nicholson, G. A., Funalot, B., Antonellis, A., Sambuughin, N., Christodoulou, K., Beggs, J. L., Zamba-Papanicolaou, E. et al. (2005). Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 128, 2304-2314.
56. Sleigh, J. N., Grice, S. J., Burgess, R. W., Talbot, K. and Cader, M. Z. (2014). Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum. Mol. Genet. 23, 2639-2650.
57. Sofou, K., Kollberg, G., Holmström, M., Dávila, M., Darin, N., Gustafsson, C. M., Holme, E., Oldfors, A., Tulinius, M. and Asin-Cayuela, J. (2015). Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome. Mol. Genet. Genomic. Med. 3, 59-68.
58. Stacklies, W., Redestig, H., Scholz, M., Walther, D. and Selbig, J. (2007). pcaMethods-a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164-1167.
59. Timmerman, V., Strickland, A. V. and Züchner, S. (2014). Genetics of Charcot-Marie-Tooth (CMT) disease within the frame of the human genome project success. Genes 5, 13-32.
60. van den Berg, R. A., Hoefsloot, H. C., Westerhuis, J. A., Smilde, A. K. and van der Werf, M. J. (2006). Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7, 142.
61. Vapnik, V. N. (1995). The Nature of Statistical Learning Theory. New York: Springer.
62. Verhamme, C., de Haan, R. J., Vermeulen, M., Baas, F., de Visser, M. and van Schaik, I. N. (2009). Oral high dose ascorbic acid treatment for one year in young CMT1A patients: A randomised, double-blind, placebo-controlled phase II trial. BMC Med. 7, 70.
63. Vester, A., Velez-Ruiz, G., McLaughlin, H. M., NISC Comparative Sequencing Program, Lupski, J. R., Talbot, K., Vance, J. M., Züchner, S., Roda, R. H., Fischbeck, K. H. et al. (2013). A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum. Mutat. 34, 191-199.
64. Xia, J., Psychogios, N., Young, N. and Wishart, D. S. (2009). MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652-W660.
65. Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. and Wishart, D. S. (2012). MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127-W133.
66. Zhu, Q., Couillard-Despreœ, S. and Julien, J.-P. (1997). Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148, 299-316.